Angiopoietin-like protein 4 (ANGPTL4) is induced by high glucose in retinal pigment epithelial cells and exhibits potent angiogenic activity on retinal endothelial cells

Acta Ophthalmologica

Volumn 91, Issue 4, 2013, Pages

  Yokouchi, Hirotaka ^a,b   Eto, Koki ^a   Nishimura, Wataru ^a   Takeda, Norio ^c   Kaburagi, Yasushi ^a,c   Yamamoto, Shuichi ^b   Yasuda, Kazuki ^a  

^a Research Institute   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

ANGPTL4; diabetic retinopathy; high glucose; retinal angiogenesis; retinal endothelial cell; retinal pigment epithelial cell

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOPOIETIN 4; EARLY GROWTH RESPONSE FACTOR 1; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION;

ANGIOPOIETINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DIABETIC RETINOPATHY; GENE EXPRESSION REGULATION; HUMANS; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NEOVASCULARIZATION, PATHOLOGIC; PIGMENT EPITHELIUM OF EYE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84878464743     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12097     Document Type: Article

References (43)

1. Aiello LP, Avery RL, Arrigg PG, et al., (1994): Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487.
2. Antonetti DA, Barber AJ, Bronson SK, et al., (2006): Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55: 2401-2411.
3. Auerbach R, Lewis R, Shinners B, Kubai L, &, Akhtar N, (2003): Angiogenesis assays: a critical overview. Clin Chem 49: 32-40.
4. Belanger AJ, Lu H, Date T, et al., (2002): Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 34: 765-774.
5. Bryan JA 3rd, &, Campochiaro PA, (1986): A retinal pigment epithelial cell-derived growth factor(s). Arch Ophthalmol 104: 422-425.
6. Camenisch G, Pisabarro MT, Sherman D, et al., (2002): ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 277: 17281-17290.
7. Campochiaro PA, Sugg R, Grotendorst G, &, Hjelmeland LM, (1989): Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp Eye Res 49: 217-227.
8. Cazes A, Galaup A, Chomel C, et al., (2006): Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99: 1207-1215.
9. Dhanabal M, LaRochelle WJ, Jeffers M, et al., (2002): Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res 62: 3834-3841.
10. Dunn KC, Marmorstein AD, Bonitha VL, et al., (1998): Use of ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5. Invest Ophthalmol Vis Sci 39: 2744-2749.
11. Dutton S, &, Trayhurn P, (2008): Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br J Nutr 100: 18-26.
12. Folkman J, (1986): How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 46: 467-473.
13. Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H, &, Hori S, (2006): Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 113: 294-301.
14. Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, &, Corvera S, (2008): Enhanced angiogenesis in obesity and in response to PPAR gamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 295: 1056-1064.
15. Goh YY, Pal M, Chong HC, et al., (2010): Angiopoietin-like 4 interacts with intergins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol 177: 2791-2803.
16. Hermann LM, Pinkerton M, Jennings K, et al., (2005): Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin Immunol 115: 93-101.
17. Hernández C, Fonollosa A, García-Ramírez M, Higuera M, Catalán R, Miralles A, García-Arumí J, &, Simó R, (2006): Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 29: 2028-2033.
18. Hewitt AT, &, Adler R, (1997): The retinal pigment epithelium and interphotoreceptor matrix: structure and specialized functions. In:, Ryan SJ, (eds). Retina, Vol. 1. St. Louis, MO: CB Mosby 57-81.
19. Huang RL, Teo Z, Chong HC, et al., (2011): ANGPTL4 modulates vascular junction integrity by integrin signaling and disrupts intercellular VE-cadherin and claudin-5 clusters. Blood 118: 3990-4002.
20. Ito Y, Oike Y, Yasunaga K, et al., (2003): Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 63: 6651-6657.
21. Kersten S, Mandard S, Tan NS, et al., (2000): Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275: 28488-28493.
22. Kim I, Kim HG, Kim H, Kim HH, Park SK, Uhm CS, Lee ZH, &, Koh GY, (2000): Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 346: 603-610.
23. Köster A, Chao YB, Mosior M, et al., (2005): Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146: 4943-4950.
24. Kubota Y, Oike Y, Satoh S, et al., (2005): Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proc Natl Acad Sci USA 102: 13502-13507.
25. Le Jan S, Amy C, Cazes A, et al., (2003): Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 162: 1521-1528.
26. Maxwell TJ, Bendall ML, Staples J, Jarvis T, &, Crandall KA, (2010): Phylogenetics applied to genotype/phenotype association and selection analyses with sequence data from angptl4 in humans. Int J Mol Sci 11: 370-385.
27. Miller EC, Capps BE, Sanghani RR, Clemmons DR, &, Maile LA, (2007): Regulation of IGF-I signaling in retinal endothelial cells by hyperglycemia. Invest Ophthalmol Vis Sci 48: 3878-3887.
28. Nishimura W, Yao I, Iida J, Tanaka N, &, Hata Y, (2002): Interaction of synaptic scaffolding molecule and Beta -catenin. J Neurosci 22: 757-765.
29. Oike Y, Ito Y, Maekawa H, et al., (2004): Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 103: 3760-3765.
30. Oike Y, Akao M, Kubota Y, &, Suda T, (2005): Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 11: 473-479.
31. Perdiguero EG, Galaup A, Durand M, et al., (2011): Alteration of developmental and pathological retinal angiogenesis in angptl4-deficient mice. J Biol Chem 286: 36841-36851.
32. Sango K, Suzuki T, Yanagisawa H, Takaku S, Hirooka H, Tamura M, &, Watabe K, (2006): High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32. J Neurochem 98: 446-458.
33. Silverman ES, &, Collins T, (1999): Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 154: 665-670.
34. Sone H, Kawakami Y, Okuda Y, Kondo S, Hanatani M, Suzuki H, &, Yamashita K, (1996): Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 221: 193-198.
35. Steele FR, Chader GJ, &, Johnson LV, (1992): Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 90: 1526-1530.
36. Sukhatme VP, Cao XM, Chang LC, et al., (1988): A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37-43.
37. Watanabe D, Suzuma K, Suzuma I, et al., (2005a): Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 139: 476-481.
38. Watanabe D, Suzuma K, Matsui S, et al., (2005b): Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353: 782-792.
39. Williamson JR, Chang K, Frangos M, et al., (1993): Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813.
40. Yamada T, Ozaki N, Kato Y, Miura Y, &, Oiso Y, (2006): Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem Biophys Res Commun 347: 1138-1144.
41. Yokoyama T, Yamane K, Minamoto A, et al., (2006): High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells. Exp Eye Res 83: 602-609.
42. Yoon JC, Chickering TW, Rosen ED, et al., (2000): Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol 20: 5343-5349.
43. Young TA, Wang H, Munk S, Hammoudi DS, Young DS, Mandelcorn MS, &, Whiteside CI, (2005): ascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp Eye Res 80: 651-662.